3Stutsky AS,Tremblay LN.Multivle system organ failure.Is mecha nical yentilation a contributing factor[J]? Am J Respir Crit Care Med, 1998,157:1721-1725.
4Dreyfuss D, Saurnon G Ventilator induced lung injury lessons from experiment studies[J].Am J Respir Crit Med, 1998, 157:294-323.
6Day RW, Allen EM,Witte MK.A randmaized controlled study of the 1 hour and 24 hour effects of inhaled nitric oxide therapy in children with acute hyroxemic respiratory failure[J].Chest, 1997,112:1324.
7Micheal JR, Barton RG, Saffie JR, et al.Inhaled nitric oxide versus conventional therapy [J].Am J Respir Crit Care Med,1998,157:1372-1380.
3[1]Lewis JF, Jobe AN. Surfactant and the adult respiratory distress syndrome[J]. Am Rev Respir Dis, 1993; 147:218～233
4[2]Taeusch HW. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy[J]. Biol Neonate, 2000;77(suppl 1) :2～8
5[3]Creuwels LA, Van Golde LM, Haagsman HP. The pulmonary sur factant system: biochemical and clinical aspects [J]. Lung, 1997;175:1～39
6[4]Vadas P, Stefanski E, Wloch M, et al . Seeretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobrone [J]. Eur J Biochem, 1996; 235:557～563
7[5]Hidi R, Vial D, Havet N, et al . Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophage[J]. Biochim pharmacol, 1997; 54(9): 1055～1058
8[6]Doyle IR, Bersten AD, Nicholas TE, et al . Surfactant protein-A and-B are elevated in plasma of patients with acute respiratory failure [J]. Am J Respir Crit Care Med, 1997; 156(4 pt 1) : 1217～1229
9[7]Greene KE, Ke S, Mason RJ, et al . Serum surfactant orotein-A levels predict development of ARDS in at-risk patients[J ]. Am J Respir Crit Care Med, 1999; 160(6): 1843～1850
10[8]Sood SL, Balaraman V, Finn KC, et al . Exogenous surfactants in a piglet model of acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 1996; 153(2) :820～828
